{
    "id": "47160921",
    "text": "5F-AB-PINACA is an indazole-based synthetic cannabinoid that is derived from a series of compounds originally developed by Pfizer in 2009 as an analgesic medication, and has been sold online as a designer drug. 5F-AB-PINACA has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.48 nM and 2.6 nM respectively. Its metabolism has been described in literature. ==Legality== ===China=== As of October 2015 5F-AB-PINACA is a controlled substance in China. ===Germany=== 5F-AB-PINACA is an Anlage II controlled substance in Germany as of May 2015. ===Singapore=== It is also controlled under the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015. == See also == * 5F-ADB * 5F-AMB * 5F-CUMYL-PINACA * AB-FUBINACA * AB-CHFUPYCA * AB-PINACA * ADB-CHMINACA * ADB-FUBINACA * ADB- PINACA * ADBICA * APICA * APINACA * MDMB-CHMICA * PX-3 == References == Category:Cannabinoids Category:Designer drugs Category:Indazolecarboxamides Category:Organofluorides Category:CB1 receptor agonists Category:CB2 receptor agonists ",
    "title": "5F-AB-PINACA"
}